Does refining the phenotype improve replication rates? A review and replication of candidate gene studies on Major Depressive Disorder and Chronic Major Depressive Disorder

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 171, Issue 2, 2016, Pages 215-236

  Luo, Xiaochen ^a   Stavrakakis, Nikolaos ^a   Penninx, Brenda W ^a,b,c   Bosker, Fokko J ^a   Nolen, Willem A ^a   Boomsma, Dorret I ^d   de Geus, Eco J ^d   Smit, Johan H ^c   Snieder, Harold ^a   Nolte, Ilja M ^a   Hartman, Catharina A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Candidate genes; Chronic depression; Genome wide association study; Major depressive disorder; Replication; Severe depression

Indexed keywords

ADK GENE; ARNTL GENE; ARTICLE; CREB1 GENE; DISEASE SEVERITY; GENE; GENE DELETION; GENE FREQUENCY; GENE MAPPING; GENE NUMBER; GENE REPLICATION; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HTR1A GENE; MAJOR DEPRESSION; MICROSATELLITE MARKER; MTHFR GENE; MYT1L GENE; NR1D GENE; PDE11A GENE; PDE4B GENE; PHENOTYPE; POMC GENE; PRIORITY JOURNAL; PSMB4 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SLC6A2 GENE; TSNAX GENE; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; HUMAN; REPRODUCIBILITY;

DEPRESSIVE DISORDER, MAJOR; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS;

EID: 84958241084     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32396     Document Type: Article

References (105)

1. Angunsri R, Sritharathikhun T, Suttirat S, Tencomnao T. 2009. Association of angiotensin-converting enzyme gene promoter single nucleotide polymorphisms and haplotype with major depression in a northeastern thai population. J Renin Angiotensin Aldosterone Syst 10:179-184.
2. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders American Psychiatric Association. Washington, DC.
3. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. 1961. An inventory for measuring depression. Arch Gen Psychiatry 4:561-571.
4. Bonvicini C, Minelli A, Scassellati C, Bortolomasi M, Segala M, Sartori R, Giacopuzzi M, Gennarelli M. 2010. Serotonin transporter gene polymorphisms and treatment-resistant depression. Prog Neuropsychopharmacol Biol Psychiatry 34:934-939.
5. Boomsma DI, Willemsen G, Sullivan PF, Heutink P, Meijer P, Sondervan D, Kluft C, Smit G, Nolen WA, Zitman FG, Smit JH, Hoogendijk WJ, van Dyck R, de Geus EJ, Penninx BW. 2008. Genome-wide association of major depression: Description of samples for the GAIN major depressive disorder study: NTR and NESDA biobank projects. Eur J Hum Genet 16:335-342.
6. Bosker FJ, Hartman CA, Nolte IM, Prins BP, Terpstra P, Posthuma D, van Veen T, Willemsen G, DeRijk RH, de Geus EJ, Hoogendijk WJ, Sullivan PF, Penninx BW, Boomsma DI, Snieder H, Nolen WA. 2011. Poor replication of candidate genes for major depressive disorder using genome-wide association data. Mol Psychiatry 16:516-532.
7. Bromet EJ, Dunn LO, Connell MM, Dew MA, Schulberg HC. 1986. Long-term reliability of diagnosing lifetime major depression in a community sample. Arch Gen Psychiatry 43:435-440.
8. Cerri AP, Arosio B, Viazzoli C, Confalonieri R, Vergani C, Annoni G. 2010. The -308 (G/A) single nucleotide polymorphism in the TNF-alpha gene and the risk of major depression in the elderly. Int J Geriatr Psychiatry 25:219-223.
9. Chen P, Huang K, Zhou G, Zeng Z, Wang T, Li B, Wang Y, He L, Feng G, Shi Y. 2011. Common SNPs in CSF2RB are associated with major depression and schizophrenia in the chinese han population. World J Biol Psychiatry 12:233-238.
10. Claes S, Myint AM, Domschke K, Del-Favero J, Entrich K, Engelborghs S, De Deyn P, Mueller N, Baune B, Rothermundt M. 2011. The kynurenine pathway in major depression: Haplotype analysis of three related functional candidate genes. Psychiatry Res 188:355-360.
11. Clerici M, Arosio B, Mundo E, Cattaneo E, Pozzoli S, Dell'osso B, Vergani C, Trabattoni D, Altamura AC. 2009. Cytokine polymorphisms in the pathophysiology of mood disorders. CNS Spectr 14:419-425.
12. Cohen-Woods S, Craig IW, McGuffin P. 2013. The current state of play on the molecular genetics of depression. Psychol Med 43:673-687.
13. Costa B, Pini S, Gabelloni P, Abelli M, Lari L, Cardini A, Muti M, Gesi C, Landi S, Galderisi S, Mucci A, Lucacchini A, Cassano GB, Martini C. 2009. Oxytocin receptor polymorphisms and adult attachment style in patients with depression. Psychoneuroendocrinology 34:1506-1514.
14. Dong C, Wong ML, Licinio J. 2009. Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: Association with major depression and antidepressant response in mexican-americans. Mol Psychiatry 14:1105-1118.
15. Flint J, Kendler KS. 2014. The genetics of major depression. Neuron 81:484-503.
16. Foley DL, Neale MC, Kendler KS. 1998. Reliability of a lifetime history of major depression: Implications for heritability and co-morbidity. Psychol Med 28:857-870.
17. Frodl T, Zill P, Baghai T, Schule C, Rupprecht R, Zetzsche T, Bondy B, Reiser M, Moller HJ, Meisenzahl EM. 2008. Reduced hippocampal volumes associated with the long variant of the tri- and diallelic serotonin transporter polymorphism in major depression. Am J Med Genet B Neuropsychiatr Genet 147B(1):1003-1007.
18. Fujii T, Yamamoto N, Hori H, Hattori K, Sasayama D, Teraishi T, Hashikura M, Tatsumi M, Okamoto N, Higuchi T, Kunugi H. 2011. Support for association between the Ser205Leu polymorphism of p75(NTR) and major depressive disorder. J Hum Genet 56:806-809.
19. Fukuo Y, Kishi T, Kushima I, Yoshimura R, Okochi T, Kitajima T, Matsunaga S, Kawashima K, Umene-Nakano W, Naitoh H, Inada T, Nakamura J, Ozaki N, Iwata N. 2011. Possible association between ubiquitin-specific peptidase 46 gene and major depressive disorders in the japanese population. J Affect Disord 133:150-157.
20. Gass N, Ollila HM, Utge S, Partonen T, Kronholm E, Pirkola S, Suhonen J, Silander K, Porkka-Heiskanen T, Paunio T. 2010. Contribution of adenosine related genes to the risk of depression with disturbed sleep. J Affect Disord 126:134-139.
21. Gelabert E, Subira S, Garcia-Esteve L, Navarro P, Plaza A, Cuyas E, Navines R, Gratacos M, Valdes M, Martin-Santos R. 2012. Perfectionism dimensions in major postpartum depression. J Affect Disord 136:17-25.
22. 1000 Genomes Project Consortium. 2010. A map of human genome variation from population-scale sequencing. Nature 467:1061-1073.
23. Gratacos M, Costas J, de Cid R, Bayes M, Gonzalez JR, Baca-Garcia E, de Diego Y, Fernandez-Aranda F, Fernandez-Piqueras J, Guitart M, Martin-Santos R, Martorell L, Menchon JM, Roca M, Saiz-Ruiz J, Sanjuan J, Torrens M, Urretavizcaya M, Valero J, Vilella E, Estivill X, Carracedo A. 2009. Psychiatric Genetics Network Group.. Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment. Am J Med Genet B Neuropsychiatr Genet 150B:808-816.
24. Green EK, Grozeva D, Jones I, Jones L, Kirov G, Caesar S, Gordon-Smith K, Fraser C, Forty L, Russell E, Hamshere ML, Moskvina V, Nikolov I, Farmer A, McGuffin P, Wellcome Trust Case Control Consortium, Holmans PA, Owen MJ, O'Donovan MC, Craddock N. 2010. The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol Psychiatry 15:1016-1022.
25. Haenisch B, Linsel K, Bruss M, Gilsbach R, Propping P, Nothen MM, Rietschel M, Fimmers R, Maier W, Zobel A, Hofels S, Guttenthaler V, Gothert M, Bonisch H. 2009. Association of major depression with rare functional variants in norepinephrine transporter and serotonin1A receptor genes. Am J Med Genet B Neuropsychiatr Genet 150B(1):1013-1016.
26. Hashimoto R, Hashimoto H, Shintani N, Ohi K, Hori H, Saitoh O, Kosuga A, Tatsumi M, Iwata N, Ozaki N, Kamijima K, Baba A, Takeda M, Kunugi H. 2010. Possible association between the pituitary adenylate cyclase-activating polypeptide (PACAP) gene and major depressive disorder. Neurosci Lett 468:300-302.
27. Hek K, Mulder CL, Luijendijk HJ, van Duijn CM, Hofman A, Uitterlinden AG, Tiemeier H. 2010. The PCLO gene and depressive disorders: Replication in a population-based study. Hum Mol Genet 19:731-734.
28. Holmans P, Zubenko GS, Crowe RR, DePaulo JRJr, Scheftner WA, Weissman MM, Zubenko WN, Boutelle S, Murphy-Eberenz K, MacKinnon D, McInnis MG, Marta DH, Adams P, Knowles JA, Gladis M, Thomas J, Chellis J, Miller E, Levinson DF. 2004. Genomewide significant linkage to recurrent, early-onset major depressive disorder on chromosome 15q. Am J Hum Genet 74:1154-1167.
29. Howie BN, Donnelly P, Marchini J. 2009. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 5:e1000529.
30. Huang SY, Lin MT, Lin WW, Huang CC, Shy MJ, Lu RB. 2009. Association of monoamine oxidase A (MAOA) polymorphisms and clinical subgroups of major depressive disorders in the han chinese population. World J Biol Psychiatry 10:544-551.
31. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. 1993. The lifetime history of major depression in women reliability of diagnosis and heritability. Arch Gen Psychiatry 50:863-870.
32. Kendler KS, Gatz M, Gardner CO, Pedersen NL. 2007. Clinical indices of familial depression in the swedish twin registry. Acta Psychiatr Scand 115:214-220.
33. Kessler RC, Ustun TB. 2004. The world mental health (WMH) survey initiative version of the world health organization (WHO) composite international diagnostic interview (CIDI). Int J Methods Psychiatr Res 13:93-121.
34. Kim JJ, Mandelli L, Pae CU, De Ronchi D, Jun TY, Lee C, Paik IH, Patkar AA, Steffens D, Serretti A, Han C. 2008. Is there protective haplotype of dysbindin gene (DTNBP1) 3 polymorphisms for major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 32:375-379.
35. Kishi T, Yoshimura R, Fukuo Y, Kitajima T, Okochi T, Matsunaga S, Inada T, Kunugi H, Kato T, Yoshikawa T, Ujike H, Umene-Nakano W, Nakamura J, Ozaki N, Serretti A, Correll CU, Iwata N. 2011. The CLOCK gene and mood disorders: A case-control study and meta-analysis. Chronobiol Int 28:825-833.
36. Kishi T, Kitajima T, Tsunoka T, Okumura T, Ikeda M, Okochi T, Kinoshita Y, Kawashima K, Yamanouchi Y, Ozaki N, Iwata N. 2009. Possible association of prokineticin 2 receptor gene (PROKR2) with mood disorders in the japanese population. Neuromolecular Med 11:114-122.
37. Kishi T, Tsunoka T, Ikeda M, Kawashima K, Okochi T, Kitajima T, Kinoshita Y, Okumura T, Yamanouchi Y, Inada T, Ozaki N, Iwata N. 2009. Serotonin 1A receptor gene and major depressive disorder: An association study and meta-analysis. J Hum Genet 54:629-633.
38. Kishi T, Yoshimura R, Kitajima T, Okochi T, Okumura T, Tsunoka T, Yamanouchi Y, Kinoshita Y, Kawashima K, Fukuo Y, Naitoh H, Umene-Nakano W, Inada T, Nakamura J, Ozaki N, Iwata N. 2010. SIRT1 gene is associated with major depressive disorder in the japanese population. J Affect Disord 126:167-173.
39. Kishi T, Yoshimura R, Okochi T, Fukuo Y, Kitajima T, Okumura T, Tsunoka T, Kawashima K, Yamanouchi Y, Kinoshita Y, Umene-Nakano W, Naitoh H, Nakamura J, Ozaki N, Iwata N. 2010. Association analysis of SIGMAR1 with major depressive disorder and SSRI response. Neuropharmacology 58:1168-1173.
40. Kloiber S, Kohli MA, Brueckl T, Ripke S, Ising M, Uhr M, Menke A, Unschuld PG, Horstmann S, Salyakina D, Muller-Myhsok B, Binder EB, Holsboer F, Lucae S. 2010. Variations in tryptophan hydroxylase 2 Linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression. Mol Psychiatry 15:736-747.
41. Kocabas NA, Faghel C, Barreto M, Kasper S, Linotte S, Mendlewicz J, Noro M, Oswald P, Souery D, Zohar J, Massat I. 2010. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: A case-control association study. Int Clin Psychopharmacol 25:218-227.
42. Koido K, Eller T, Kingo K, Koks S, Traks T, Shlik J, Vasar V, Vasar E, Maron E. 2010. Interleukin 10 family gene polymorphisms are not associated with major depressive disorder and panic disorder phenotypes. J Psychiatr Res 44:275-277.
43. Lekman M, Laje G, Charney D, Rush AJ, Wilson AF, Sorant AJ, Lipsky R, Wisniewski SR, Manji H, McMahon FJ, Paddock S. 2008. The FKBP5-gene in depression and treatment response-an association study in the sequenced treatment alternatives to relieve depression (STAR*D) cohort. Biol Psychiatry 63:1103-1110.
44. Lewis CM, Ng MY, Butler AW, Cohen-Woods S, Uher R, Pirlo K, Weale ME, Schosser A, Paredes UM, Rivera M, Craddock N, Owen MJ, Jones L, Jones I, Korszun A, Aitchison KJ, Shi J, Quinn JP, Mackenzie A, Vollenweider P, Waeber G, Heath S, Lathrop M, Muglia P, Barnes MR, Whittaker JC, Tozzi F, Holsboer F, Preisig M, Farmer AE, Breen G, Craig IW, McGuffin P. 2010. Genome-wide association study of major recurrent depression in the U.K. population. Am J Psychiatry 167:949-957.
45. Licinio J, Dong C, Wong ML. 2009. Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response. Arch Gen Psychiatry 66:488-497.
46. Lin CH, Chang YY, Lung FW. 2009. Sex-specific interaction between MAOA promoter polymorphism and apo epsilon 2 allele in major depressive disorder in the chinese population. Psychiatr Genet 19:337.
47. Lin E, Hong CJ, Hwang JP, Liou YJ, Yang CH, Cheng D, Tsai SJ. 2009. Gene-gene interactions of the brain-derived neurotrophic-factor and neurotrophic tyrosine kinase receptor 2 genes in geriatric depression. Rejuvenation Res 12:387-393.
48. Liou YJ, Chen TJ, Tsai SJ, Yu YW, Cheng CY, Hong CJ. 2009. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment. Pharmacogenet Genomics 19:735-741.
49. Liou YJ, Chen TJ, Tsai SJ, Yu YW, Chen SY, Cheng CY, Hong CJ. 2011. Evidence of involvement of the human par-4 (PAWR) gene in major depressive disorder. World J Biol Psychiatry 12:288-295.
50. Liu Z, Liu W, Xiao Z, Wang G, Yin S, Zhu F, Wang H, Cheng J, Wang X, He X, Li W. 2008. A major single nucleotide polymorphism of the PDLIM5 gene associated with recurrent major depressive disorder. J Psychiatry Neurosci 33:43-46.
51. Liu J, Li J, Li T, Wang T, Li Y, Zeng Z, Li Z, Chen P, Hu Z, Zheng L, Ji J, Lin H, Feng G, Shi Y. 2011. CTLA-4 confers a risk of recurrent schizophrenia, major depressive disorder and bipolar disorder in the chinese han population. Brain Behav Immun 25:429-433.
52. Lung FW, Tzeng DS, Huang MF, Lee MB. 2011. Association of the MAOA promoter uVNTR polymorphism with suicide attempts in patients with major depressive disorder. BMC Med Genet 12:74.
53. Marchini J, Howie B, Myers S, McVean G, Donnelly P. 2007. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 39:906-913.
54. Massat I, Kocabas NA, Crisafulli C, Chiesa A, Calati R, Linotte S, Kasper S, Fink M, Antonijevic I, Forray C, Snyder L, Bollen J, Zohar J, De Ronchi D, Souery D, Serretti A, Mendlewicz J. 2011. COMT and age at onset in mood disorders: A replication and extension study. Neurosci Lett 498:218-221.
55. McGuffin P, Cohen S, Knight J. 2007. Homing in on depression genes. Am J Psychiatry 164:195-197.
56. Mickey BJ, Zhou Z, Heitzeg MM, Heinz E, Hodgkinson CA, Hsu DT, Langenecker SA, Love TM, Pecina M, Shafir T, Stohler CS, Goldman D, Zubieta JK. 2011. Emotion processing, major depression, and functional genetic variation of neuropeptide Y. Arch Gen Psychiatry 68:158-166.
57. Monteleone P, Bifulco M, Maina G, Tortorella A, Gazzerro P, Proto MC, Di Filippo C, Monteleone F, Canestrelli B, Buonerba G, Bogetto F, Maj M. 2010. Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression. Pharmacol Res 61:400-404.
58. Muglia P, Tozzi F, Galwey NW, Francks C, Upmanyu R, Kong XQ, Antoniades A, Domenici E, Perry J, Rothen S, Vandeleur CL, Mooser V, Waeber G, Vollenweider P, Preisig M, Lucae S, Muller-Myhsok B, Holsboer F, Middleton LT, Roses AD. 2010. Genome-wide association study of recurrent major depressive disorder in two european case-control cohorts. Mol Psychiatry 15:589-601.
59. Nakataki M, Iga J, Numata S, Yoshimoto E, Kodera K, Watanabe SY, Song H, Ueno S, Ohmori T. 2011. Gene expression and association analysis of the epithelial membrane protein 1 gene in major depressive disorder in the japanese population. Neurosci Lett 489:126-130.
60. Numata S, Iga J, Nakataki M, Tayoshi S, Tanahashi T, Itakura M, Ueno S, Ohmori T. 2009. Positive association of the pericentrin (PCNT) gene with major depressive disorder in the japanese population. J Psychiatry Neurosci 34:195-198.
61. Numata S, Iga J, Nakataki M, Tayoshi S, Taniguchi K, Sumitani S, Tomotake M, Tanahashi T, Itakura M, Kamegaya Y, Tatsumi M, Sano A, Asada T, Kunugi H, Ueno S, Ohmori T. 2009. Gene expression and association analyses of the phosphodiesterase 4B (PDE4B) gene in major depressive disorder in the japanese population. Am J Med Genet B Neuropsychiatr Genet 150B:527-534.
62. Okuda A, Kishi T, Okochi T, Ikeda M, Kitajima T, Tsunoka T, Okumukura T, Fukuo Y, Kinoshita Y, Kawashima K, Yamanouchi Y, Inada T, Ozaki N, Iwata N. 2010. Translin-associated factor X gene (TSNAX) may be associated with female major depressive disorder in the japanese population. Neuromolecular Med 12:78-85.
63. Onaivi ES, Ishiguro H, Gong JP, Patel S, Meozzi PA, Myers L, Perchuk A, Mora Z, Tagliaferro PA, Gardner E, Brusco A, Akinshola BE, Liu QR, Chirwa SS, Hope B, Lujilde J, Inada T, Iwasaki S, Macharia D, Teasenfitz L, Arinami T, Uhl GR. 2008. Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression. Ann N Y Acad Sci 1139:434-449.
64. Philibert RA, Beach SR, Gunter TD, Todorov AA, Brody GH, Vijayendran M, Elliott L, Hollenbeck N, Russell D, Cutrona C. 2011. The relationship of deiodinase 1 genotype and thyroid function to lifetime history of major depression in three independent populations. Am J Med Genet B Neuropsychiatr Genet 156B:593-599.
65. Rainero I, Ostacoli L, Rubino E, Gallone S, Picci LR, Fenoglio P, Negro E, Rosso C, De Martino P, De Marchi M, Furlan PM, Pinessi L. 2011. Association between major mood disorders and the hypocretin receptor 1 gene. J Affect Disord 130:487-491.
66. Rietschel M, Beckmann L, Strohmaier J, Georgi A, Karpushova A, Schirmbeck F, Boesshenz KV, Schmal C, Burger C, Jamra RA, Schumacher J, Hofels S, Kumsta R, Entringer S, Krug A, Markov V, Maier W, Propping P, Wust S, Kircher T, Nothen MM, Cichon S, Schulze TG. 2008. G72 and its association with major depression and neuroticism in large population-based groups from germany. Am J Psychiatry 165:753-762.
67. Rietschel M, Mattheisen M, Frank J, Treutlein J, Degenhardt F, Breuer R, Steffens M, Mier D, Esslinger C, Walter H, Kirsch P, Erk S, Schnell K, Herms S, Wichmann HE, Schreiber S, Jockel KH, Strohmaier J, Roeske D, Haenisch B, Gross M, Hoefels S, Lucae S, Binder EB, Wienker TF, Schulze TG, Schmal C, Zimmer A, Juraeva D, Brors B, Bettecken T, Meyer-Lindenberg A, Muller-Myhsok B, Maier W, Nothen MM, Cichon S. 2010. Genome-wide association-, replication-, and neuroimaging study implicates HOMER1 in the etiology of major depression. Biol Psychiatry 68:578-585.
68. Rivera M, Gutierrez B, Molina E, Torres-Gonzalez F, Bellon JA, Moreno-Kustner B, King M, Nazareth I, Martinez-Gonzalez LJ, Martinez-Espin E, Munoz-Garcia MM, Motrico E, Martinez-Canavate T, Lorente JA, Luna JD, Cervilla JA. 2009. High-activity variants of the uMAOA polymorphism increase the risk for depression in a large primary care sample. Am J Med Genet B Neuropsychiatr Genet 150B:395-402.
69. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. 1996. The inventory of depressive symptomatology (IDS): Psychometric properties. Psychol Med 26:477-486.
70. Sarosi A, Gonda X, Balogh G, Domotor E, Szekely A, Hejjas K, Sasvari-Szekely M, Faludi G. 2008. Association of the STin2 polymorphism of the serotonin transporter gene with a neurocognitive endophenotype in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 32:1667-1672.
71. Schosser A, Gaysina D, Cohen-Woods S, Chow PC, Martucci L, Craddock N, Farmer A, Korszun A, Gunasinghe C, Gray J, Jones L, Tozzi F, Perry J, Muglia P, Owen MJ, Craig IW, McGuffin P. 2010. Association of DISC1 and TSNAX genes and affective disorders in the depression case-control (DeCC) and bipolar affective case-control (BACCS) studies. Mol Psychiatry 15:844-849.
72. Schosser A, Gaysina D, Cohen-Woods S, Domenici E, Perry J, Tozzi F, Korszun A, Gunasinghe C, Gray J, Jones L, Binder EB, Holsboer F, Craddock N, Owen MJ, Craig IW, Farmer AE, Muglia P, McGuffin P. 2011. A follow-up case-control association study of tractable (druggable) genes in recurrent major depression. Am J Med Genet B Neuropsychiatr Genet 156B:640-650.
73. Shen X, Wu Y, Qian M, Wang X, Hou Z, Liu Y, Sun J, Zhong H, Yang J, Lin M, Li L, Guan T, Shen Z, Yuan Y. 2011. Tryptophan hydroxylase 2 gene is associated with major depressive disorder in a female chinese population. J Affect Disord 133:619-624.
74. Shi J, Potash JB, Knowles JA, Weissman MM, Coryell W, Scheftner WA, Lawson WB, DePaulo JR, Jr, Gejman PV, Sanders AR, Johnson JK, Adams P, Chaudhury S, Jancic D, Evgrafov O, Zvinyatskovskiy A, Ertman N, Gladis M, Neimanas K, Goodell M, Hale N, Ney N, Verma R, Mirel D, Holmans P, Levinson DF. 2011. Genome-wide association study of recurrent early-onset major depressive disorder. Mol Psychiatry 16:193-201.
75. Soria V, Martinez-Amoros E, Escaramis G, Valero J, Crespo JM, Gutierrez-Zotes A, Bayes M, Martorell L, Vilella E, Estivill X, Menchon JM, Gratacos M, Urretavizcaya M. 2010a. Resequencing and association analysis of arylalkylamine N-acetyltransferase (AANAT) gene and its contribution to major depression susceptibility. J Pineal Res 49:35-44.
76. Soria V, Martinez-Amoros E, Escaramis G, Valero J, Perez-Egea R, Garcia C, Gutierrez-Zotes A, Puigdemont D, Bayes M, Crespo JM, Martorell L, Vilella E, Labad A, Vallejo J, Perez V, Menchon JM, Estivill X, Gratacos M, Urretavizcaya M. 2010b. Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder. Neuropsychopharmacology 35:1279-1289.
77. Soronen P, Mantere O, Melartin T, Suominen K, Vuorilehto M, Rytsala H, Arvilommi P, Holma I, Holma M, Jylha P, Valtonen HM, Haukka J, Isometsa E, Paunio T. 2011. P2RX7 gene is associated consistently with mood disorders and predicts clinical outcome in three clinical cohorts. Am J Med Genet B Neuropsychiatr Genet 156B:435-447.
78. Suchanek R, Owczarek A, Kowalczyk M, Kucia K, Kowalski J. 2011. Association between C-281A and val66met functional polymorphisms of BDNF gene and risk of recurrent major depressive disorder in polish population. J Mol Neurosci 43:524-530.
79. Sullivan PF, Neale MC, Kendler KS. 2000. Genetic epidemiology of major depression: Review and meta-analysis. Am J Psychiatry 157:1552-1562.
80. Sun N, Xu Y, Wang Y, Duan H, Wang S, Ren Y, Peng J, Du Q, Shen Y, Xu Q, Zhang K. 2008. The combined effect of norepinephrine transporter gene and negative life events in major depression of chinese han population. J Neural Transm 115:1681-1686.
81. Sun RF, Zhu YS, Kuang WJ, Liu Y, Li SB. 2011. The G-712A polymorphism of brain-derived neurotrophic factor is associated with major depression but not schizophrenia. Neurosci Lett 489:34-37.
82. Szczepankiewicz A, Leszczynska-Rodziewicz A, Pawlak J, Rajewska-Rager A, Dmitrzak-Weglarz M, Wilkosc M, Skibinska M, Hauser J. 2011. Glucocorticoid receptor polymorphism is associated with major depression and predominance of depression in the course of bipolar disorder. J Affect Disord 134:138-144.
83. Tabor HK, Risch NJ, Myers RM. 2002. Candidate-gene approaches for studying complex genetic traits: Practical considerations. Nat Rev Genet 3:391-397.
84. Taylor WD, Zuchner S, McQuoid DR, Steffens DC, Speer MC, Krishnan KR. 2007. Allelic differences in the brain-derived neurotrophic factor Val66Met polymorphism in late-life depression. Am J Geriatr Psychiatry 15:850-857.
85. Togsverd M, Werge TM, Tanko LB, Bagger YZ, Hansen T, Qin G, Christiansen C, Rasmussen HB. 2008. Association of a dopamine beta-hydroxylase gene variant with depression in elderly women possibly reflecting noradrenergic dysfunction. J Affect Disord 106:169-172.
86. Tsai SJ, Hong CJ, Liou YJ, Yu YW, Chen TJ. 2008. Plasminogen activator inhibitor-1 gene is associated with major depression and antidepressant treatment response. Pharmacogenet Genomics 18:869-875.
87. Tsai SJ, Hong CJ, Liou YJ, Yu YW, Chen TJ, Hou SJ, Yen FC. 2009. Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response. Prog Neuropsychopharmacol Biol Psychiatry 33:637-641.
88. Tsunoka T, Kishi T, Ikeda M, Kitajima T, Yamanouchi Y, Kinoshita Y, Kawashima K, Okochi T, Okumura T, Inada T, Ozaki N, Iwata N. 2009. Association analysis of group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a japanese population. Prog Neuropsychopharmacol Biol Psychiatry 33:875-879.
89. Unschuld PG, Ising M, Specht M, Erhardt A, Ripke S, Heck A, Kloiber S, Straub V, Brueckl T, Muller-Myhsok B, Holsboer F, Binder EB. 2009. Polymorphisms in the GAD2 gene-region are associated with susceptibility for unipolar depression and with a risk factor for anxiety disorders. Am J Med Genet B Neuropsychiatr Genet 150B(1):1100-1109.
90. Van Den Eede F, Venken T, Del-Favero J, Norrback KF, Souery D, Nilsson LG, Van den Bossche B, Hulstijn W, Sabbe BG, Cosyns P, Mendlewicz J, Adolfsson R, Van Broeckhoven C, Claes SJ. 2007. Single nucleotide polymorphism analysis of corticotropin-releasing factor-binding protein gene in recurrent major depressive disorder. Psychiatry Res 153:17-25.
91. Verma R, Cutler DJ, Holmans P, Knowles JA, Crowe RR, Scheftner WA, Weissman MM, DePaulo JR, Jr, Levinson DF, Potash JB. 2007. Investigating the role of p11 (S100A10) sequence variation in susceptibility to major depression. Am J Med Genet B Neuropsychiatr Genet 144B(1):1079-1082.
92. Viikki M, Anttila S, Kampman O, Illi A, Huuhka M, Setala-Soikkeli E, Mononen N, Lehtimaki T, Leinonen E. 2010a. Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression. Neurosci Lett 477:105-108.
93. Viikki M, Kampman O, Illi A, Setala-Soikkeli E, Anttila S, Huuhka M, Nuolivirta T, Poutanen O, Mononen N, Lehtimaki T, Leinonen E. 2010b. TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response. Neurosci Lett 468:80-84.
94. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V. 2013. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the global burden of disease study. The Lancet 380:2163-2196.
95. Wang T, Zeng Z, Li T, Liu J, Li J, Li Y, Zhao Q, Wei Z, Wang Y, Li B, Feng G, He L, Shi Y. 2010. Common SNPs in myelin transcription factor 1-like (MYT1L): Association with major depressive disorder in the chinese han population. PLoS ONE 5:e13662.
96. Wang HC, Yeh TL, Chang HH, Gean PW, Chi MH, Yang YK, Lu RB, Chen PS. 2011. TPH1 is associated with major depressive disorder but not with SSRI/SNRI response in taiwanese patients. Psychopharmacology (Berl) 213:773-779.
97. Wong ML, Dong C, Maestre-Mesa J, Licinio J. 2008. Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response. Mol Psychiatry 13:800-812.
98. Wray NR, James MR, Gordon SD, Dumenil T, Ryan L, Coventry WL, Statham DJ, Pergadia ML, Madden PA, Heath AC, Montgomery GW, Martin NG. 2009. Accurate, large-scale genotyping of 5HTTLPR and flanking single nucleotide polymorphisms in an association study of depression, anxiety, and personality measures. Biol Psychiatry 66:468-476.
99. Wu Y, Xu Y, Sun Y, Wang YF, Li X, Lang XE, Wang WP, Zhang KR. 2008. Association between the serotonin 1A receptor C(-1019)G polymorphism and major depressive disorder in the northern han ethnic group in china. Chin Med J (Engl) 121:874-876.
100. Wu GS, Luo HR, Dong C, Mastronardi C, Licinio J, Wong ML. 2011. Sequence polymorphisms of MC1R gene and their association with depression and antidepressant response. Psychiatr Genet 21:14-18.
101. Yoon HK, Kim YK. 2009. TPH2-703G/T SNP may have important effect on susceptibility to suicidal behavior in major depression. Prog Neuropsychopharmacol Biol Psychiatry 33:403-409.
102. You J, Yuan Y, Zhang Z, Zhang X, Li H, Qian Y. 2010. A preliminary association study between brain-derived neurotrophic factor (BDNF) haplotype and late-onset depression in mainland chinese. J Affect Disord 120:165-169.
103. Zhang K, Yang C, Xu Y, Sun N, Yang H, Liu J, Xu Q, Shen Y. 2010. Genetic association of the interaction between the BDNF and GSK3B genes and major depressive disorder in a chinese population. J Neural Transm 117:393-401.
104. Zobel A, Jessen F, von Widdern O, Schuhmacher A, Hofels S, Metten M, Rietschel M, Scheef L, Block W, Becker T, Schild HH, Maier W, Schwab SG. 2008. Unipolar depression and hippocampal volume: Impact of DNA sequence variants of the glucocorticoid receptor gene. Am J Med Genet B Neuropsychiatr Genet 147B:836-843.
105. Zobel A, Schuhmacher A, Jessen F, Hofels S, von Widdern O, Metten M, Pfeiffer U, Hanses C, Becker T, Rietschel M, Scheef L, Block W, Schild HH, Maier W, Schwab SG. 2010. DNA sequence variants of the FKBP5 gene are associated with unipolar depression. Int J Neuropsychopharmacol 13:649-660.